Cargando…
Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus
Through the action of two virus-encoded decapping enzymes (D9 and D10) that remove protective caps from mRNA 5′-termini, Vaccinia virus (VACV) accelerates mRNA decay and limits activation of host defenses. D9- or D10-deficient VACV are markedly attenuated in mice and fail to counter cellular double-...
Autores principales: | Burgess, Hannah M., Pourchet, Aldo, Hajdu, Cristina H., Chiriboga, Luis, Frey, Alan B., Mohr, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991893/ https://www.ncbi.nlm.nih.gov/pubmed/29888320 http://dx.doi.org/10.1016/j.omto.2018.01.001 |
Ejemplares similares
-
Poxvirus-encoded decapping enzymes promote selective translation of viral mRNAs
por: Cantu, Fernando, et al.
Publicado: (2020) -
Vaccinia virus D10 has broad decapping activity that is regulated by mRNA splicing
por: Ly, Michael, et al.
Publicado: (2022) -
A Poxvirus Decapping Enzyme Colocalizes with Mitochondria To Regulate RNA Metabolism and Translation and Promote Viral Replication
por: Cao, Shuai, et al.
Publicado: (2022) -
CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
por: Pourchet, Aldo, et al.
Publicado: (2016) -
Elimination of cap structures generated by mRNA decay involves the new scavenger mRNA decapping enzyme Aph1/FHIT together with DcpS
por: Taverniti, Valerio, et al.
Publicado: (2015)